| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Prepaid expenses and other current assets | 9,867 | |||
| Cash and cash equivalents | 31,423 | |||
| Short-term investments | 207,811 | |||
| Total current assets | 249,101 | |||
| Restricted cash | 227 | |||
| Property and equipment, net | 47 | |||
| Other non-current assets | 2,609 | |||
| Operating lease right-of-use asset | 127 | |||
| Long-term investments | 17,184 | |||
| Total assets | 269,295 | |||
| Accrued expenses and other current liabilities | 6,780 | |||
| Operating lease liability, current portion | 145 | |||
| Accounts payable | 3,170 | |||
| Total current liabilities | 10,095 | |||
| Other liabilities | 8 | |||
| Operating lease liability, net of current portion | 0 | |||
| Total liabilities | 10,103 | |||
| Accumulated deficit | -181,323 | |||
| Common stock, 0.0001 par value 140,000,000 voting shares authorized as of june30, 2025 and december31, 2024, 25,692,268 and 25,617,805 voting shares issued and outstanding as of june30, 2025 and december31, 2024, respectively 10,000,000 non-voting shares authorized as of june30, 2025 and december31, 2024, no non-voting shares issued or outstanding as of june30, 2025 or december31, 2024 | 3 | |||
| Additional paid-in capital | 440,391 | |||
| Accumulated other comprehensive income | 121 | |||
| Total stockholders equity | 259,192 | |||
| Total liabilities and stockholders equity | 269,295 | |||
Tourmaline Bio, Inc. (TRML)
Tourmaline Bio, Inc. (TRML)